Non-alcoholic steatohepatitis: from cell biology to clinical practice.
about
Insulin resistance in development and progression of nonalcoholic fatty liver diseaseHerbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospectsReview article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?Liver disease in cystic fibrosis: an updateHepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patientsInflammation in nonalcoholic steatohepatitis.Prevention of steatosis by hepatic JNK1Metformin in nonalcoholic steatohepatitis: a randomized controlled trialRole of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice.Linoleate appears to protect against palmitate-induced inflammation in Huh7 cellsN-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitisDiffering endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.Gender-related variations in iron metabolism and liver diseases.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver diseaseThe endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openingsCarotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic Fatty liver disease.Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchPathogenesis and management issues for non-alcoholic fatty liver diseaseRegular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus.Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanismIrritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome.Histological assessment of non-alcoholic fatty liver disease.Role of Kupffer cells in host defense and liver disease.Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis.Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease.Present and future therapeutic strategies in non-alcoholic fatty liver disease.Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis.A chat on fat in liverProsteatotic and Protective Components in a Unique Model of Fatty Liver: Gut Microbiota and Suppressed Complement SystemImpact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease.Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.Clinical approaches to non-alcoholic fatty liver diseaseEzetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs.Chemotherapy-associated hepatotoxicity: how concerned should we be?Nonalcoholic fatty liver disease: a challenge for pediatricians.Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.
P2860
Q26748687-0858589D-810D-4C0A-AE6B-B8F9A5BBA635Q26828615-AE31803F-FC1D-4F34-9DE3-E64DAFB94124Q26998093-60C5940C-684B-4C91-9D2D-8B10A952BA29Q28662082-49E727F3-17A2-4664-80F1-55511B36E5E2Q28748743-AF2886EB-9139-4BA7-A09B-698359AC4023Q30453231-8D5FEA03-5644-454C-885C-3AE82D378563Q33580974-9BAD146F-53EB-4BE5-A18D-09662294FF41Q33597395-F228E6EE-BD98-481F-B607-8A734650B32FQ33645106-50501AD6-2598-4842-BBA4-113A1AD32CF5Q33684205-530B6B93-2BC9-4A22-A560-C2A0BB352829Q34109325-69242AC3-238D-4492-9858-0E539E9F4ABCQ34166238-F031A621-83AC-44CC-BCCD-3929C03D136FQ34391646-F5173E75-5903-4AD2-B7F9-5C6D1BF5C2E8Q34412650-A3DCC056-B26C-46A8-91B3-1E9E73C3D886Q34551170-9AFFA346-1783-44AC-B4A5-DBAB73633E79Q34988788-395CB968-61AF-4581-A111-5CE00EB19C3EQ35193292-0B8E154D-DDFD-418C-A65F-11EC2DF6CCD4Q35902576-4DDDE1F6-133F-4F7E-BD23-2AE931260007Q35976733-EEBC0112-B8C3-49C6-BBD3-FB4367039F3FQ36129673-EC34AEB7-B3D9-4B64-8D1C-ECFFC7E93744Q36179902-A87D7921-F370-44E0-B17F-8F5CABA77FD4Q36184201-F308FBCE-71B9-45F0-A131-8E2D7FE4CC08Q36199008-ED7C5639-8653-4B6C-B77E-4B41D0C1018FQ36418677-A20AADED-BF9D-48B3-ABC0-81F26F74C087Q36634377-3B287FD2-0320-4DDE-B21D-1E2C81476FEFQ36653858-189B8BDC-C054-4313-B76D-E74E3BD6C998Q36803083-0CE5C9D1-DCC8-40FC-9003-55483866E628Q36860745-CE84D87D-44ED-4FA6-80F7-4130A35564BEQ36936358-BFA497F9-0CBF-4DA3-840A-CCC49565BFCCQ36961972-BBCAB8CB-A3B7-4A4F-9564-E114C4A9E0D1Q37138370-15655844-2AAA-41B0-8CBA-9D7E1A41EFB1Q37195612-8B64B646-B753-461B-80DF-6F6437D0385AQ37345871-E4ABB7D8-FDF9-4833-869A-30C9081EE862Q37441293-FD3CF91B-4DAA-451B-A17C-0C319E134F33Q37520561-E4710272-A989-4C59-8F73-E8765D8B08A6Q37596187-2736448E-E94D-413D-9409-74B81643A815Q37620806-52C006FA-3AC9-44D0-8CF4-CEF9789CE472Q37732281-6D219BA6-9342-4B86-8E1F-017B6302B106Q37788538-F50BF0C8-24F2-478D-A024-D357238BA8D7Q37858449-8FADC314-6C1A-41B4-AFD4-DF0C659BF579
P2860
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
@ast
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
@en
type
label
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
@ast
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
@en
prefLabel
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
@ast
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
@en
P2093
P1476
Non-alcoholic steatohepatitis: from cell biology to clinical practice.
@en
P2093
Christopher Paul Day
Helena Cortez-Pinto
Miguel Carneiro de Moura
P304
P356
10.1016/J.JHEP.2005.09.002
P577
2005-10-06T00:00:00Z